论文部分内容阅读
为了对慢性活动性肝炎在经过激素治疗后,在组织学上转变为慢性持续性肝炎患者的预后进行正确的估计,作者对52例患者进行了系统的观察。这些患者均为成人,入院时平均年龄为36±2岁(18~75岁),男性20例,女性32例,临床、生化和病理学检查均证实为慢性活动性肝炎(中、重型门管周围性肝炎24例、桥型坏死16例、多叶性坏死12例)。在经过18±2个月(6~61个月)的强的松计划治疗,达到临床症状消失、肝功能恢复正常,并经组织学证实为慢性持续性肝炎者,即予停药并作为观察对象。观察
In order to make a correct estimate of the prognosis of patients with chronic active hepatitis who have undergone hormonal therapy and who have been histologically converted to chronic persistent hepatitis, 52 patients were systematically observed. All of these patients were adults and had an average age of 36 ± 2 years (18 to 75 years) at admission, 20 males and 32 females. Chronic active hepatitis was confirmed by clinical, biochemical and pathological examinations 24 cases of peripheral hepatitis, 16 cases of bridging necrosis, 12 cases of lobar necrosis). After 18 ± 2 months (6 ~ 61 months) of prednisone treatment plan to achieve the disappearance of clinical symptoms, liver function returned to normal, and histologically proved to be chronic persistent hepatitis, that withdrawal and as an observation Object Observed